News
MRK
129.56
+3.34%
4.19
Merck (MRK) Stock Trades At A Discount To Cash Flow But A Premium To Earnings
Simply Wall St · 3h ago
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?
NASDAQ · 12h ago
Is Merck’s Expanding Oncology, Vaccine and HIV Portfolio Altering The Investment Case For Merck (MRK)?
Simply Wall St · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of July 5
Seeking Alpha · 1d ago
Best ETFs to Invest In, According to AI Analyst, 7/2/2026
TipRanks · 1d ago
Merck's Post-Keytruda Playbook Is Working, But Valuation Has Caught Up
Seeking Alpha · 1d ago
VOO vs. SCHD: Which ETF Should You Buy?
TipRanks · 1d ago
Merck abandons phase 2 Alzheimer's candidate
Seeking Alpha · 2d ago
Merck terminates Phase 2 Alzheimer’s study
TipRanks · 2d ago
Merck (MRK) Wins New Drug Approvals As Its Undervalued Narrative Faces A Fresh Test
Simply Wall St · 2d ago
Dimensional U.S. Equity Market ETF Experiences Big Inflow
NASDAQ · 2d ago
Press Release: Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
Dow Jones · 2d ago
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
Barchart · 2d ago
Verizon Leads July's 'Safer' Dogs Of The Dow; Nike Near 'Ideal'
Seeking Alpha · 3d ago
Johnson & Johnson snaps six straight sessions of gains
Seeking Alpha · 3d ago
Merck & Co snapped after six days rally
Seeking Alpha · 3d ago
Bristol, Merck, AbbVie face House committee probe over China trials
Seeking Alpha · 3d ago
RFK Jr. ends Emergency Use Authorizations for COVID-19 drugs
Seeking Alpha · 3d ago
AI Daily: Amazon’s AWS commits $1B toward new unit
TipRanks · 3d ago
Merck Price Target Raised to $141.00/Share From $130.00 by B of A Securities
Dow Jones · 3d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.